Home › Research › What the research found › Every row
Every row of the evidence table
One row per finding: what was tested, which way the result went, and how the study was built. The answer by area, and where the studies disagree, are on the main page.
Every row
Filter
Showing 9 of 382 rows. One row per study per exposure: a study that tested two different things appears twice, once for each.
Scroll the table sideways to see every column.
| Exposure | Question | Direction | Outcome measured | Design | People | Effect size, as the source reported it | Source |
|---|---|---|---|---|---|---|---|
| Multidomain lifestyle intervention Exercise and activity | Prevention |
Benefit
whyCompared with flexible health advice, not with nothing; both groups improved. |
Global cognitive composite (SD per year) over 2 years | randomised trial | 1,065 | Between-group difference in global cognitive composite 0.11 SD per year (95% CI 0.06-0.15) |
The Lancet
2026 ✓ Peer-reviewed PMID 42442374 |
| Multidomain lifestyle intervention Exercise and activity | Prevention |
No effect
whyThe intervention did not change any brain biomarker trajectory. Participants with lower baseline hippocampal volume did show a greater cognitive benefit. |
Amyloid, tau, hippocampal volume and white matter trajectories | randomised trial | 983 | Cognitive benefit of structured vs self-guided: 0.077 SD (95% CI 0.022-0.132) with lower hippocampal volume vs 0.002 SD (95% CI -0.037 to 0.041) with higher |
JAMA Neurology
2026 ✓ Peer-reviewed PMID 42008251 |
| Multidomain lifestyle intervention Exercise and activity | Prevention |
Benefit
whyBoth groups improved; the structured programme improved more. The trial compares two active interventions, so there is no untreated comparison. |
Global cognition (SD per year) over 2 years | randomised trial | 2,111 | Structured 0.243 SD/year vs. self-guided 0.213 SD/year; difference 0.029 SD/year |
JAMA
2025 ✓ Peer-reviewed PMID 40720610 |
| Multidomain lifestyle intervention Exercise and activity | Prevention |
No effect
whyA small improvement that did not reach significance (adjusted difference 0.06, 95% CI -0.001 to 0.128, p=0.055). |
Neuropsychological Test Battery at 24 months | randomised trial | 746 | Adjusted mean difference in NTB score at 24 months 0.06 (95% CI -0.001 to 0.128, p=0.055) |
The Lancet Healthy Longevity
2025 ✓ Peer-reviewed PMID 41130254 |
| Multidomain lifestyle intervention Exercise and activity | Prevention | Benefit | Neuropsychological test battery Z-score at 2 years | randomised trial | 1,260 | NTB Z-score change 0.20 (intervention) vs. 0.16 (control); annual between-group difference 0.022 |
The Lancet
2015 ✓ Peer-reviewed PMID 25771249 |
| Physical activity (general / dose) Exercise and activity | Prevention |
No effect
whyNeither the combined package nor risk-factor modification beat health advice. |
ADAS-Cog z-score at 15 months | randomised trial | 456 | ADAS-Cog z-score difference vs health advice: -0.04 (95% CI -0.34 to 0.26) for combined package |
The Lancet Healthy Longevity
2025 ✓ Peer-reviewed PMID 40294622 |
| Physical activity (general / dose) Exercise and activity | Treatment |
Harm
whyThe primary cognitive outcome was significantly WORSE in the exercise arm (adjusted difference -1.4, 95% CI -2.6 to -0.2, favouring usual care). The authors conclude the programme does not slow cognitive impairment and treat the difference as of uncertain clinical importance. Fitness did improve. This is the sharpest counterweight to the observational exercise evidence. |
ADAS-cog at 12 months (primary) | randomised trial | 494 | ADAS-cog adjusted difference -1.4 (95% CI -2.6 to -0.2) favouring usual care |
BMJ
2018 ✓ Peer-reviewed PMID 29769247 |
| Resistance training Exercise and activity | Prevention |
No effect
whyThe primary outcome did not move between groups. Attention and inhibitory control did improve (SMD 0.43), as did muscular strength. |
Executive function at 24 weeks (primary) | randomised trial | 90 | Between-group executive function SMD 0.13 (P=0.37); attention/inhibitory control SMD 0.43 (P<0.001) |
Alzheimer's & Dementia
2026 ✓ Peer-reviewed PMID 41562376 |
| Resistance training Exercise and activity | Prevention |
Benefit
whyThe authors call the effect small (-0.18 points). Significant in women, not in men, on 91 randomised and 76 completing. |
ADAS-Cog-Plus at 12 months | randomised trial | 91 | ADAS-Cog-Plus mean difference -0.18 (95% CI -0.35 to -0.01; P=0.04) |
Alzheimer's & Dementia
2026 ✓ Peer-reviewed PMID 41795685 |